Table 8.3 The hepatic extraction values of some drugs
DrugEHvalue<0.3 (low) DrugEHvalue 0.3–0.7 DrugEHvalue>0.7 (high)
Antripyrine Aspirin Cocaine
Diazepam Codeine Lignocaine
Nitrazepam Nifedipine Nicotine
Warfarin Nortriptyline Propranolol
a specific region of the body, to be taken into account when assessing the
pharmacokinetic behaviour of the drug in that region of the body (see section
8.5). Clearance values enable the medicinal chemist to compare the effect of
structural changes on drug behaviour and as a result decide which analogues
might yield drugs with the desired pharmacokinetic properties. Extraction ratios
can also be used to link the required desirable characteristics of a potential new
drug with the chemical structures of the analogues of a lead. Their use can lead
to the avoidance of the loss of a potential drug by indicating the most effective
dosage form.
8.4.3 Intravenous infusion
In intravenous infusion, the drug is infused into the vein at a steady rate. Initially,
the plasma concentration of the drug increases as the amount of the infused drug
exceeds the amount of the drug being eliminated (Figure 8.7). However, as the
concentration of the drug in the plasma increases, the rate of elimination
also increases, until the rate of infusion is equal to the rate of elimination, at
which point the concentration of the drug in the plasma remains constant. As
long as the infusion rate is kept constant, the drug plasma concentration will
remain at this steady state level (Css). When infusion is stopped the drug
Time t
Cp Infusion
started
Infusion
stopped
Css........................
Steady state
Figure 8.7 Plasma concentration changes with time in intravenous infusion
INTRAVASCULAR ADMINISTRATION 169